Stay updated on Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe page adds a new revision (v3.3.3) and removes the HHS Vulnerability Disclosure text along with the prior revision note (v3.3.2).SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedFooter revision tag updated from 'Revision: v3.2.0' to 'Revision: v3.3.2'. This is a minor UI/version label change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding notice banner was removed from the page, and the study record history remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedThe history list now includes additional submission entries for the SWITCH PRO study (NCT03687827), documenting updates to study status and recruitment/locations. These entries reflect ongoing changes to the trial's status and site information.SummaryDifference0.1%

- Check85 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference10%

- Check93 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec vs Glargine in Type 2 Diabetes Clinical Trial page.